BIVI - Company ID 0001580149
BIOVIE INC. trades as BIVI. This page tracks BIOVIE INC. through 481 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-11 |
| SCHEDULE 13D | - | 2026-03-25 |
| Quarterly report | 10-Q | 2026-02-06 |
| Insider trade | 4 | 2026-01-09 |
| Insider trade | 4 | 2026-01-09 |
| Insider trade | 4 | 2026-01-09 |
| Insider trade | 4 | 2026-01-09 |
| Insider trade | 4 | 2026-01-09 |
The largest companies sharing BIOVIE INC.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year BIOVIE INC. reported a net loss of $17.54M.